A plausible withdrawal-associated cardiac event still needs the cardiac and exposure evidence.
What the study found
A case report described acute cardiac dysfunction and a Takotsubo pattern in the context of benzodiazepine withdrawal. Clinical and ventricular abnormalities improved during treatment, with later recovery documented.
Recovery supported a hypothesis, not a shortcut diagnosis
The case documented cardiac dysfunction and subsequent recovery in a withdrawal context, with normal biventricular function reported at later follow-up. Improvement after treatment is one piece of a clinical causal assessment. It does not allow a benzodiazepine prescription gap, by itself, to diagnose Takotsubo syndrome or exclude coronary and other causes of acute cardiac illness in a different patient.
Limits of interpretation
One case cannot establish incidence or prove that withdrawal was the only trigger. Acute illness, stress, other medicines and concurrent cardiac care can affect both presentation and improvement.
Implications for case review
Reconstruct the last confirmed use, withdrawal symptoms and cardiac investigations separately. A missed prescription alone does not establish withdrawal-induced cardiomyopathy. Equally, absence of a direct toxic overdose does not exclude a medication-related withdrawal pathway. The opinion must address competing explanations and the full course.
Source and related reading
Source: PMC10996924, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Epilepsy Tissue Findings Came From Patients With Extensive Medication Exposure.
Leave a Reply